NCT07272161
Pilot Evaluation of the StarGuide Next Generation SPECT/CT System
Enrolling by Invitation
NAAges 18+InterventionalDiagnosticMayo ClinicInvestigator-initiated
~100 participants
Updated 2026-04-06 on ClinicalTrials.gov
What's tested:StarGuide NextGen SPECT/CT system
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Diagnostic image quality
Measured over 1 year
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Carrie B. Hruska, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Scheduled for clinical administration of a radiopharmaceutical for a clinical nuclear medicine imaging test or radiopharmaceutical therapy
Able to provide consent for study participation StarGuide NextGen Evaluation
Exclusion
Unable to comply with physical requirements for lying supine on the StarGuide NextGen patient bed
Pregnant. (Note that pregnancy status will be established via clinical standard of care for the clinical nuclear medicine test prior to administration of radiopharmaceutical.)
Unable to provide consent for study participation
What this trial measures
- Diagnostic image quality1 year
Diagnostic image quality of StarGuide NextGen and clinical scans, will be assessed by study radiologists using a Likert scale of 1-5, where 1 = Non-diagnostic; 2 = Poor; 3 = Adequate; 4 = Good; and 5 = Excellent. For future clinical use, acceptable image quality will be considered as having scores of 4 or 5.